Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-01 Sale |
2021-12-03 4:02 pm |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
200,000 | $5.09 | $1,018,000 | 1,470,565 (Indirect Direct) |
View |
| 2021-02-09 Sale |
2021-02-10 5:06 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
20,000 | $5 | $100,000 | 1,307,457 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 4:33 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
40,000 | $5.0008 | $200,032 | 1,327,457 (Direct) |
View |
| 2020-07-23 Sale |
2020-07-27 5:27 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
20,000 | $5.01 | $100,200 | 1,367,457 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-24 Option Award |
2023-05-26 4:12 pm |
2023-05-24 2033-05-24 |
Arbutus Biopharma Corp | ABUS | Torti Frank Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-26 4:06 pm |
2023-05-24 2033-05-24 |
Arbutus Biopharma Corp | ABUS | Meyers James R Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:12 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
418,400 | $0 | 1,725,857 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:11 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
410,900 | $0 | 1,881,465 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:11 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
395,000 | $0 | 395,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:10 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | Collier William H. President and CEO |
1,082,500 | $0 | 1,082,500 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:10 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | Howard Elizabeth EVP, GC, Compliance |
348,400 | $0 | 364,724 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:19 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:17 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:16 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | Meyers James R Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:15 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | Torti Frank Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:13 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | Tran Tram Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:10 pm |
2022-05-25 2032-05-25 |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:55 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | Collier William H. President and CEO |
787,550 | $2.81 | 787,550 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:55 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
285,000 | $2.81 | 285,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:54 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | Howard Elizabeth Chief Compliance Officer |
237,500 | $2.81 | 237,500 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:54 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
285,000 | $2.81 | 285,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:54 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | Picchio Gaston Chief Development Officer |
256,500 | $2.81 | 256,500 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:53 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
325,850 | $2.81 | 325,850 (Direct) |
View |
| 2021-11-09 Option Award |
2021-11-12 06:22 am |
N/A 2031-11-09 |
Arbutus Biopharma Corp | ABUS | Tran Tram Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2021-10-18 Conversion |
2021-10-20 5:14 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | Roivant Sciences Ltd. 10% Owner |
23,997,922 | $0 | 38,847,462 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:25 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:25 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:25 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | Meyers James R Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:24 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:24 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | Cheng Andrew Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:24 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | Torti Frank Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 5:08 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | Picchio Gaston Chief Development Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 5:06 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 5:00 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | Collier William H. President and CEO |
675,000 | $0 | 675,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 4:57 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | Howard Elizabeth Chief Compliance Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 4:55 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
249,000 | $0 | 249,000 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 4:52 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
290,000 | $0 | 290,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 4:06 pm |
N/A 2020-02-17 |
Arbutus Biopharma Corp | ABUS | Picchio Gaston Chief Development Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 4:05 pm |
N/A 2030-02-17 |
Arbutus Biopharma Corp | ABUS | Collier William H. President and CEO |
70,000 | $0 | 70,000 (Direct) |
View |